Skip to main content
. Author manuscript; available in PMC: 2019 Feb 2.
Published in final edited form as: Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 28;81:114–121. doi: 10.1016/j.pnpbp.2017.10.019

Table 1.

Sample Demographics

Patients
(N=27)
Healthy Volunteers
(N=23)
Statistical Test df p value
Age (SD), years 23.8 (5.4) 26.3 (7.1) t = 1.45 48 NS
Sex (Male/Female) 20M/7F 11M/12F χ2 = 3.63 1 NS
Handedness (R, L)1 8/17 11/12 χ2 = 1.26 1 NS
Education (years)2 13.0 (1.8) 14.9 (2.4) t = 3.16 46 .003
Brief Psychiatric Rating Scale 43.5 (6.3)
MATRICS Consensus Cognitive Battery T Score3
 Attention 34.6 (10.7)
 Reasoning/Problem Solving 44.8 (9.1)
 Social Cognition 38.0 (10.2)
 Speed of Processing 34.6 (8.4)
 Verbal Memory 34.3 (6.1)
 Visual Processing 40.1 (11.6)
 Working Memory 40.1 (12.0)
 Overall Functioning 31.8 (5.1)
Antipsychotics received prior to MRI4
 Risperidone 22
 Latuda 1
 Olanzapine 2
 Haloperidol 1
 Valproic Acid 1
 Quetiapine 1
 Ziprasidone 1

Note: Means are provided with standard deviations in parentheses.

1

Data were unavailable for 2 patients.

2

Data were unavailable for 1 patient and 1 healthy volunteer.

3

Data were unavailable for 3 patients on the reasoning/problem solving, speed of processing, verbal functioning, visual functioning, and working memory domains. Five individuals were missing attention scores and 7 individuals (including 1 outlier > 3 SD from the mean) were missing social cognition scores.

4

Data were unavailable for 3 patients